| Unknown | Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Old COVID-19, Coronavirus Infections, Respiratory Tract Infections | Phase 2 / Phase 3 | 2022-10-24 |
| Unknown | Tolerability, Safety and Immunogenicity Trial of the Flu-M Tetra Vaccine in Children Influenza, Influenza, Human, Influenza Viral Infections | Phase 3 | 2022-01-19 |
| Completed | Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine. COVID-19, Immunologic Factors, Coronavirus Infections | Phase 1 / Phase 2 | 2021-07-19 |
| Completed | Tolerability, Safety and Immunogenicity Trial of the FLU-M® Tetra Influenza | Phase 2 / Phase 3 | 2021-03-04 |
| Completed | Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Influenza, Human, Vaccination; Infection, Vaccines | Phase 3 | 2021-02-16 |
| Completed | Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Ye Influenza, Flu, Human | Phase 3 | 2020-12-07 |
| Completed | Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vac Influenza, Influenza, Human, Influenza Viral Infections | Phase 2 / Phase 3 | 2020-10-06 |
| Completed | The Objectives of This Study Are Study the Immunogenicity and Safety of the Flu-M [Inactivated Split Influenza Influenza | Phase 3 | 2020-03-03 |
| Completed | Tolerability and Reactogenicity Trial of the Recombinant Tuberculosis Allergen in Healthy Volunteers Tuberculosis, Skin Tests | Phase 1 | 2020-02-13 |
| Completed | The Objectives of This Study Are Comparative Assessment of the Tolerability, Safety and Immunogenicity of the Influenza | Phase 3 | 2020-02-10 |
| Completed | Trial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine Influenza, Human, Vaccination; Infection, Vaccines | Phase 3 | 2020-01-23 |
| Completed | Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae T Haemophilus Influenzae Infection, Vaccines | Phase 1 | 2020-01-14 |
| Completed | The Objectives of This Study Are Study the Safety, Reactogenicity and Obtain Preliminary Data on the Immunogen Influenza | Phase 1 | 2019-11-16 |
| Completed | Trial of the Reactogenicity, Safety and Immunogenicity of the Flu-M Vaccine Manufactured by FSUE SPbSRIVS FMBA Influenza | Phase 2 | 2016-10-24 |
| Completed | The Objectives of This Study Are Study of the Reactogenicity, Safety and Immunogenicity of Flu-M Inactivated S Influenza | Phase 1 | 2016-03-09 |